MedTrace Logo

A Chatbot To Support Substance Use Recovery

NCT06845878 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2026-04-20

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if/how an AI chatbot can support patients who in recovery for substance use, specifically those who are receiving medication for opioid use disorder.

Can the chatbot help lower drug use? Can the chatbot help improve clinical appointment adherence? Can the chatbot help patients build self-efficacy in leading their own recovery journey? Will the chatbot help reduce workload burden for primary care teams? Can the chatbot serve as a safe, useful and engaging tool to support patients?

Researchers will investigate the effects of using a chatbot to support follow-up care for patients in opioid use recovery.

Participants will:

* Receive access to a chatbot for 12 weeks that they can use to prepare for upcoming clinical appointments, find community resources, learn about urge-surfing and wellness techniques, and query for assistance with other recovery-related information and tasks
* Complete surveys and provide user feedback

Conditions

  • Opiate-Related Disorders
  • Opiate Substitution Treatment

Interventions

OTHER

chatbot

Participants will: * Participate in a baseline session to complete an initial survey and get trained on using the chatbot * Use the chatbot for 12 weeks and submit a brief weekly survey to provide feedback * Complete a final survey to provide substance use and health information as well as give feedback on the experience using the chatbot * Allow access to a limited set of demographic, substance use and health information in electronic health record for study analyses and context.

Sponsors & Collaborators

Principal Investigators

  • Y. Xian Ho, PhD · Dimagi Inc.

  • Jonathan Jackson, MEng · Dimagi Inc.

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-07
Primary Completion
2026-06-01
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06845878 on ClinicalTrials.gov